Fran Justice
Fran Justice
Contact
Email
show email address
Fran Justice is a Senior Project Manager for the New Vaccines group.
Fran Justice is a Senior Project Manager for the New Vaccines group.
Top Publications
- Batmunkh, T, Moore, KA, Thomson, H, Altangerel, B, Amraa, O, Avaa, N, Batbayar, L, Batsukh, K, Bright, K, Burentogtokh, T, et al. Immunogenicity, safety, and reactogenicity of a half- versus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial.. Lancet Reg Health West Pac 42: 100953 2024 view publication
- Witte, D, Handley, A, Jere, KC, Bogandovic-Sakran, N, Mpakiza, A, Turner, A, Pavlic, D, Boniface, K, Mandolo, J, Ong, DS, et al. Neonatal rotavirus vaccine (RV3-BB) immunogenicity and safety in a neonatal and infant administration schedule in Malawi: a randomised, double-blind, four-arm parallel group dose-ranging study.. Lancet Infect Dis 22(5) : 668 -678 2022 view publication
- Witte, D, Handley, A, Jere, KC, Bogandovic-Sakran, N, Mpakiza, A, Turner, A, Pavlic, D, Boniface, K, Mandolo, J, Ong, DS, et al. Neonatal Rotavirus Vaccine (RV3-BB) Immunogenicity and Safety in a Neonatal and Infant Administration Schedule in Malawi: A Randomized, Double-Blind, Four-Arm Parallel Group Dose-Ranging Study. 2021 view publication
- Bines, JE, At Thobari, J, Satria, CD, Handley, A, Watts, E, Cowley, D, Nirwati, H, Ackland, J, Standish, J, Justice, F, et al. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.. N Engl J Med 378(8) : 719 -730 2018 view publication
- Bines, JE, Danchin, M, Jackson, P, Handley, A, Watts, E, Lee, KJ, West, A, Cowley, D, Chen, M-Y, Barnes, GL, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.. Lancet Infect Dis 15(12) : 1389 -1397 2015 view publication
Page 1 of 4
Share //
